Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up

Purpose: To evaluate medium-term clinical outcomes of transcatheter embolization and stenting in women with several pelvic venous disorders responsible for chronic pelvic pain and varicose veins of the lower limbs.Materials and Methods: The study population included 327 consecutively recruited patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Quentin Senechal, Perrine Echegut, Marine Bravetti, Marie Florin, Lamia Jarboui, Mehdi Bouaboua, Christophe Teriitehau, Jacques Feignoux, Francois Legou, Eric Pessis
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/d54a29a2eba241ed9fd903a0fec3cb0d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d54a29a2eba241ed9fd903a0fec3cb0d
record_format dspace
spelling oai:doaj.org-article:d54a29a2eba241ed9fd903a0fec3cb0d2021-11-17T07:01:34ZEndovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up2297-055X10.3389/fcvm.2021.751178https://doaj.org/article/d54a29a2eba241ed9fd903a0fec3cb0d2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.751178/fullhttps://doaj.org/toc/2297-055XPurpose: To evaluate medium-term clinical outcomes of transcatheter embolization and stenting in women with several pelvic venous disorders responsible for chronic pelvic pain and varicose veins of the lower limbs.Materials and Methods: The study population included 327 consecutively recruited patients referred to the interventional radiology unit from January 2014 to December 2019 due to chronic pelvic congestion (91; 27.83%), lower limb varices (15; 4.59%), or a combination of both the symptoms (221; 67.58%). Preprocedural pelvic, transvaginal Doppler ultrasound (US), and MRI were conducted in all the patients and revealed anatomical varicosities and incompetent pelvic veins in 312 patients. In all the patients, selective catheterization demonstrated uterine venous engorgement, ovarian plexus congestion, or pelvic vein filling. Retrograde flow was detected on catheter venography in the left ovarian vein (250; 78%), the right ovarian vein (85; 26%), the left internal iliac vein (222; 68%), and the right internal iliac vein (185; 57%). Patients were followed-up at 1, 6, and 12 months, and years thereafter systematically by the referring angiologist and the interventional radiologist of center. They were contacted by telephone in November and December 2020 to assess pain perception and quality of life by using the visual analog scales from 0 to 10 with assessments made at the baseline and last follow-up. Of the 327 patients (mean age, 42 ± 12 years), 312 patients were suffering from pelvic congestion syndrome and 236 patients was suffering from lower limb varices. All underwent embolization by using ethylene vinyl alcohol copolymer (Onyx®). Eighty-five right ovarian veins, 249 left ovarian veins, 510 tributaries of the right internal iliac vein, and 624 tributaries of the left internal iliac vein were embolized. A cohort of patients also underwent nutcracker syndrome angioplasty (6.7%) and May–Thurner syndrome angioplasty (14%) with a stent placement.Results: The initial technical success rate was 80.9% for embolization of pathological veins and 100% for stenting of stenoses. Overall, 307 patients attended 12-month follow-up visits and 288 (82%) patients completed the telephone survey at mean 39 (±18)-month postintervention. Main pelvic pain significantly improved from 6.9 (±2.4) pre- to 2.0 (±2.4) postembolization (p < 0.001), as did specific symptoms in each category. Improvement or disappearance of pain was achieved in 266/288 (92.36%) patients with improved quality of life in 276/288 (95.8%) patients. There were 16 minor and 4 major adverse events reported on the follow-up.Conclusion: Pelvic vein embolization (Onyx®) is an effective and safe procedure with high clinical success and quality of life improvement rates.Quentin SenechalPerrine EchegutMarine BravettiMarie FlorinLamia JarbouiMehdi BouabouaChristophe TeriitehauJacques FeignouxFrancois LegouEric PessisFrontiers Media S.A.articlepelvic congestion syndromechronic pelvic painpelvic vein insufficiencyembolizationpelvic venous disorderschronic pelvis vein incompetenceDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic pelvic congestion syndrome
chronic pelvic pain
pelvic vein insufficiency
embolization
pelvic venous disorders
chronic pelvis vein incompetence
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle pelvic congestion syndrome
chronic pelvic pain
pelvic vein insufficiency
embolization
pelvic venous disorders
chronic pelvis vein incompetence
Diseases of the circulatory (Cardiovascular) system
RC666-701
Quentin Senechal
Perrine Echegut
Marine Bravetti
Marie Florin
Lamia Jarboui
Mehdi Bouaboua
Christophe Teriitehau
Jacques Feignoux
Francois Legou
Eric Pessis
Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
description Purpose: To evaluate medium-term clinical outcomes of transcatheter embolization and stenting in women with several pelvic venous disorders responsible for chronic pelvic pain and varicose veins of the lower limbs.Materials and Methods: The study population included 327 consecutively recruited patients referred to the interventional radiology unit from January 2014 to December 2019 due to chronic pelvic congestion (91; 27.83%), lower limb varices (15; 4.59%), or a combination of both the symptoms (221; 67.58%). Preprocedural pelvic, transvaginal Doppler ultrasound (US), and MRI were conducted in all the patients and revealed anatomical varicosities and incompetent pelvic veins in 312 patients. In all the patients, selective catheterization demonstrated uterine venous engorgement, ovarian plexus congestion, or pelvic vein filling. Retrograde flow was detected on catheter venography in the left ovarian vein (250; 78%), the right ovarian vein (85; 26%), the left internal iliac vein (222; 68%), and the right internal iliac vein (185; 57%). Patients were followed-up at 1, 6, and 12 months, and years thereafter systematically by the referring angiologist and the interventional radiologist of center. They were contacted by telephone in November and December 2020 to assess pain perception and quality of life by using the visual analog scales from 0 to 10 with assessments made at the baseline and last follow-up. Of the 327 patients (mean age, 42 ± 12 years), 312 patients were suffering from pelvic congestion syndrome and 236 patients was suffering from lower limb varices. All underwent embolization by using ethylene vinyl alcohol copolymer (Onyx®). Eighty-five right ovarian veins, 249 left ovarian veins, 510 tributaries of the right internal iliac vein, and 624 tributaries of the left internal iliac vein were embolized. A cohort of patients also underwent nutcracker syndrome angioplasty (6.7%) and May–Thurner syndrome angioplasty (14%) with a stent placement.Results: The initial technical success rate was 80.9% for embolization of pathological veins and 100% for stenting of stenoses. Overall, 307 patients attended 12-month follow-up visits and 288 (82%) patients completed the telephone survey at mean 39 (±18)-month postintervention. Main pelvic pain significantly improved from 6.9 (±2.4) pre- to 2.0 (±2.4) postembolization (p < 0.001), as did specific symptoms in each category. Improvement or disappearance of pain was achieved in 266/288 (92.36%) patients with improved quality of life in 276/288 (95.8%) patients. There were 16 minor and 4 major adverse events reported on the follow-up.Conclusion: Pelvic vein embolization (Onyx®) is an effective and safe procedure with high clinical success and quality of life improvement rates.
format article
author Quentin Senechal
Perrine Echegut
Marine Bravetti
Marie Florin
Lamia Jarboui
Mehdi Bouaboua
Christophe Teriitehau
Jacques Feignoux
Francois Legou
Eric Pessis
author_facet Quentin Senechal
Perrine Echegut
Marine Bravetti
Marie Florin
Lamia Jarboui
Mehdi Bouaboua
Christophe Teriitehau
Jacques Feignoux
Francois Legou
Eric Pessis
author_sort Quentin Senechal
title Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
title_short Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
title_full Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
title_fullStr Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
title_full_unstemmed Endovascular Treatment of Pelvic Congestion Syndrome: Visual Analog Scale Follow-Up
title_sort endovascular treatment of pelvic congestion syndrome: visual analog scale follow-up
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/d54a29a2eba241ed9fd903a0fec3cb0d
work_keys_str_mv AT quentinsenechal endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT perrineechegut endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT marinebravetti endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT marieflorin endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT lamiajarboui endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT mehdibouaboua endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT christopheteriitehau endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT jacquesfeignoux endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT francoislegou endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
AT ericpessis endovasculartreatmentofpelviccongestionsyndromevisualanalogscalefollowup
_version_ 1718425892717330432